Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
If you want your questions answered before you start, see how semaglutide works and what care alongside it looks like
Victoza is approved purely for the management of Type 2 diabetes, not for weight loss, says Dr
Zepbound is an FDA-approved, once-weekly injectable GLP-1 medication for chronic weight management, authorized in October 2023
4 The obesity trial showed weight loss up to about 24% at 48 weeks, and the diabetes trial showed HbA1c reductions up to about 2 percentage points
She feels more confident these days
Also, by screening for and treating these comorbid conditions, hospitals widen the eligible patient pool for GLP-1s beyond conventional obesity and diabetes management
US$ 26.93
US$ 23.15
US$ 28.97
US$ 23.51
